GlassScriptPhysician profile
Leigh A Klein
NPI 1487981452
$646.09
in general payments reported to CMS, 2019-2025
15 companies · $37.85 in 2025
The $37.85 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.08 · 2022: $344 · 2023: $161 · 2024: $34.80 · 2025: $37.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $162.98 | 2021-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Corium, LLC | $103.12 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $95.87 | 2022-2023 | Jornay Pm |
| Sanofi Pasteur INC. | $48.48 | 2022-2023 | |
| Cumberland Pharmaceuticals, INC. | $45.49 | 2022 | |
| Pfizer INC. | $42.72 | 2023-2025 | |
| Evofem Biosciences, INC. | $23.49 | 2021 | |
| Mayne Pharma Commercial LLC | $20.62 | 2022 | |
| Sumitomo Pharma America, INC. | $17.78 | 2023 | Myfembree |
| Abbott Laboratories | $17.65 | 2024 | Eterna |
| Acadia Pharmaceuticals INC | $17.61 | 2023 | Daybue |
| Avion Pharmaceuticals | $17.28 | 2023 | Balcoltra |
| Lupin INC. | $14.02 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.76 | 2025 | |
| Organon LLC | $5.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.